Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Many Nurses Unintentionally Exposed to Chemotherapy

By HospiMedica International staff writers
Posted on 31 Aug 2011
Nearly 17% of nurses who work in outpatient chemotherapy-infusion centers suffer from skin or eye exposure to the toxic drugs they deliver, according to a new study.

Researchers at the University of Michigan Comprehensive Cancer Center (Ann Arbor, MI, USA) conducted a Michigan (USA) state-wide sample survey of 1,339 oncology nurses (response rate 30.4%) who reported their employment outside of hospital inpatient units, between April 2010 and June 2010. More...
The survey examined the likelihood of self-reported exposure to chemotherapy as a function of perceived quality of the practice environment, nursing workload, and seven ambulatory chemotherapy administration safety standards.

The results showed minimal demographic differences between respondents and nonrespondents, with the overall rate of exposure to the skin or eyes during the past year at 16.9%. In multivariable logistic regression models that controlled for demographic characteristics and clustering of nurses in practices, the likelihood of exposure decreased when nurses reported adequate staffing and resources, and when nurses reported that chemotherapy doses were verified by two nurses frequently or very frequently. The study was published early online on August 16, 2011, in BMJ Quality and Safety.

“We have minimized needle stick incidents so that they are rare events that elicit a robust response from administrators. Nurses go immediately for evaluation and prophylactic treatment. But we don't have that with chemotherapy exposure,” said lead author Christopher Friese, RN, PhD, an assistant professor at the University of Michigan school of nursing. “Any unintentional exposure to the skin or eyes could be just as dangerous as a needle stick.”

Unlike needle sticks, where a specific virus is involved and preventive treatments can be given, it is more difficult to link chemotherapy exposure to a direct health effect. Unintentional chemotherapy exposure can affect the nervous system, impair the reproductive system, and confer a future risk of blood cancers. Ensuring adequate staffing and resources and adherence to recognized practice standards may protect oncology nurses from harm.

Related Links:

University of Michigan Comprehensive Cancer Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.